Collaborate Disseminate
Biotechnology company Moderna, in association with The National Institute of Allergy and Infectious Diseases, has kicked off a Phase 1 human trial testing three different mRNA vaccine formulations designed to induce immunity against HIV. The trial is t… Continue reading Moderna kicks off Phase 1 trial of 3 different mRNA HIV vaccines
The immune system is incredibly complex, but a new breakthrough could help scientists unravel more of its secrets. Researchers at Harvard’s Wyss Institute have created a more accurate model of the human immune system in a microfluidic chip, providing a… Continue reading Immune-system-on-a-chip could speed up future vaccine development
We are all very familiar now with the way viral infections lead to acute disease. From the flu to COVID-19 and the measles, it is well understood how viruses lead to disease but scientists are only now discovering the broad role viral infections play in the development of other health conditions, often emerging years or even decades after the initial infection.
Category: Science
Tags: Virus, Vaccines, Cancer, Alzheimer’s Disease, Schizophrenia, Multiple Sclerosis
Continue reading The new science linking cancer, schizophrenia and MS to viral infections
Researchers at Australia’s CSIRO have demonstrated a new way to protect the integrity of vaccines against high temperatures. A proof-of-concept study has shown the method keeping vaccines viable at temperatures up to 37 degrees Celsius for three months… Continue reading New method allows vaccines to be stored for months without refrigeration
Building on the momentum of its extraordinarily successful mRNA COVID-19 vaccine, biotechnology company Moderna has announced three new mRNA development targets. The company is now setting its vaccine sights on the herpes simplex virus, the varicella-z… Continue reading Moderna announces 3 new mRNA vaccine targets including herpes and cancer
A rapid research review conducted by the UK Health Security Agency (UKHSA) has affirmed prior findings indicating vaccination reduces a person’s risk of developing long COVID. The report also found vaccination after developing long COVID can improve pe… Continue reading UK review affirms vaccination reduces risk of long COVID
New research from Iowa State University has found a long bout of moderately intense exercise following COVID-19 or influenza vaccination can amplify the body’s immune response. The study showed 90 minutes of exercise immediately after vaccination incre… Continue reading Exercising right after vaccination can boost immune response
Researchers at Georgia State University have produced a novel nanoparticle-enhanced intranasal influenza vaccine. The results of a preclinical study that have just been published demonstrate the unique nasal spray induces robust local and systemic immu… Continue reading Nanoparticle-enhanced nasal flu vaccine delivers promising early data
Many of the all-too-familiar symptoms of aging can be attributed to a build-up of senescent cells, those which have stopped dividing. In a new study, researchers in Japan have identified a protein specific to these cells and developed a vaccine that ca… Continue reading Anti-aging vaccine clears out dysfunctional cells that cause disease
This week, both Moderna and Pfizer announced they have commenced clinical trials testing Omicron-specific formulations of their mRNA COVID-19 vaccines. Data from the trials is expected in the first half of 2022, however, some experts suggest the end of… Continue reading Moderna and Pfizer launch Omicron-specific COVID vaccine trials